A Phase I Study of Swainsonine in Patients with Advanced Malignancies1

Cancer Research

Volumn 54, Issue 6, 1994, Pages 1450-1457

  Fernandes, Jose ^c   Dennis, James W ^b  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

SWAINSONINE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG CLEARANCE; DRUG HALF LIFE; DRUG MECHANISM; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKEMIA; LIVER METASTASIS; LIVER TOXICITY; LYMPHOMA; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; SOLID TUMOR;

ADULT; AGED; ALPHA-MANNOSIDASE; ANTIGENS, SURFACE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; GOLGI APPARATUS; HUMANS; INFUSIONS, INTRAVENOUS; LYMPHOCYTES; MALE; MANNOSIDASES; MIDDLE AGED; NEOPLASMS; OLIGOSACCHARIDES; SWAINSONINE;

EID: 0028328856     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Yamashita, K., Ohkura, T., Tachibana, Y., Takasaki, S., and Kobata, A. Comparative study of the oligosaccharides released from baby hamster kidney cells and their polyoma transformant by hydrazinolysis. J. Biol. Chem., 259: 10834-10840, 1984.
2. Pierce, M., and Arango, J. Rous sarcoma virus-transformed baby hamster kidney cells express higher levels of asparagine-linked tri- and tetraantennary glycopeptides containing [GlcNAc-α(1, 6)Man-α(1, 6)Man] and poly-n-acetyllactosamine sequences than baby hamster kidney cells. J. Biol. Chem., 261: 10772-10777, 1986.
3. Dennis, J.W., Kosh, K., Bryce, D.M., and Breitman, M. Oncogenes conferring metastatic potential induce increased branching of Asn-linked oligosaccharides in rat2 fibroblasts. Oncogene, 4: 853-860, 1989.
4. Dennis, J.W., Laferte, S., Waghorne, C., Breitman, M.L., and Kerbel, R.S. β1-6 branching of Asn-linked oligosaccharides is directly associated with metastasis. Science (Washington DC), 236: 582-585, 1987.
5. Dennis, J.W., and Laferte, S. Oncodevelopmental expression of -GlcNAc β1-6Man α1-6Man β1-6 branching of Asn-linked oligosaccharides in human breast carcinomas. Cancer Res., 49: 945-950, 1989.
6. Fernandes, B., Sagman, U., Auger, M., Demetrio, M., and Dennis, J.W. β1-6 branched oligosaccharides as a marker of tumor progression in human breast and colon neoplasia. Cancer Res., 51: 718-723, 1991.
7. Dennis, J.W. Different metastatic phenotypes in two genetic classes of wheat germ agglutinin-resistant tumor cell mutants. Cancer Res., 46: 4594-4600, 1986.
8. Dennis, J.W. Effects of swainsonine and polyinosinic-polycytidylic acid on murine tumor cell growth and metastasis. Cancer Res., 46: 5131-5136, 1986.
9. Humphries, M.J., Matsumoto, K., White, S.L., and Olden, K. Oligosaccharide modification by swainsonine treatment inhibits pulmonary colonization by B16-F10 murine melanoma cells. Proc. Natl. Acad. Sci. USA, 83: 1752-1756, 1986.
10. Pulverer, G., Beuth, J., Ko, H.L., Yassin, A., Ohshima, Y., Roszkowski, K., and Uhlenbruck, G. Glycoprotein modifications of sarcoma L-1 tumor cells by tunicamycin, swainsonine, bromoconduritol or 1-deoxynoijirimycin treatment inhibits their metastatic lung colonization in Balb/c-mice. J. Cancer Res. Clin. Oncol., 114: 217-220, 1988.
11. Humphries, M.J., Matsumoto, K., White, S.L., and Olden, K. Inhibition of experimental metastasis by castanospermine in mice: blockage of two distinct stages of tumor colonization by oligosaccharide processing inhibitors. Cancer Res., 46: 5215-5222, 1986.
12. Colegate, S.M., Huxtable, C.R., and Dorling, P.R. A spectroscopic investigation of swainsonine: an alpha-mannosidase inhibitor isolated from Swainsona canescens. Aust. J. Chem., 32: 2257-2264, 1979.
13. Molyneux, R.J., and James, L.F. Loco intoxication: indolizidine alkaloid of spotted locoweed. Science (Washington DC), 216: 190-191, 1981.
14. Schneider, M.J., Ungemach, F.S., Broquist, H.P., and Harris, T.M. Tetrahedron Lett., 39: 29-31, 1983.
15. Tulsiani, D.R., Harris, T.M., and Touster, O. Swainsonine inhibits the biosynthesis of complex glycoproteins by inhibition of Golgi mannosidase II.J. Biol. Chem., 257: 7936-7939, 1982.
16. Dorling, P.R., Huxtable, C.R., and Colegate, S.M. Inhibition of lysosomal alphamannosidase by swainsonine, an indolizidine alkaloid isolated from Swainsona canescens. Biochem. J., 191: 649-651, 1980.
17. DeSantis, R., Santer, U.V., and Glick, M.C. NIH 3T3 cells transfected with human tumor DNA lose the transformed phenotype when treated with swainsonine. Biochem. Biophys. Res. Commun., 142: 348-353, 1987.
18. Dennis, J.W., Koch, K., Yousefi, S., and VanderElst, I. Growth inhibition of human melanoma tumor xenografts in athymic nude mice by swainsonine. Cancer Res., 50: 1867-1872, 1990.
19. VanderElst, I., and Dennis, J.W. N-linked oligosaccharide processing and autocrinestimulation of tumor cell proliferation. Exp. Cell Res., 192: 612-613, 1991.
20. Cornil, I., Kerbel, R.S., and Dennis, J.W. Tumor cell surface β1-4 linked galactose binds to lectin(s) on microvascular endothelial cells and contributes to organ colonization. J. Cell Biol., 111: 773-782, 1990.
21. Yagel, S., Feinmesser, R., Waghorne, C., Lala, P.K., Breitman, M.L., and Dennis, J.W. Evidence that β1-6 branched Asn-linked oligosaccharides on metastatic tumor cells facilitate invasion of basement membranes. Int. J. Cancer, 44: 685-690, 1989.
22. Seftor, R.E.B., Seftor, E.A., Grimes, W.J., Liotta, L.A., Stetler-Stevenson, W.G., Welch, D.R., and Hendrix, M.J.C. Human melanoma cell invasion is inhibited in vitro by swainsonine and deoxymannojirimycin with a concomitant decrease in collagenase IV expression. Melanoma Res., 1: 43-54, 1991.
23. Humphries, M.J., Matsumoto, K., White, S.L., Molyneux, R.J., and Olden, K. Augmentation of murine natural killer cell activity by swainsonine, a new antimetastatic immunomodulator. Cancer Res., 48: 1410-1415, 1988.
24. Humphries, M.J., Matsumoto, K., White, S.L., Molyneux, R.J., and Olden, K. An assessment of the effects of swainsonine on survival of mice injected with B16-F10 melanoma cells. Clin. Exp. Metastasis, 8: 89-102, 1990.
25. Kino, T., Inamura, N., Nakahara, K., Kiyoto, S., Goto, T., Terano, H., Kohsaka, M., Oaki, H., and Imanaka, H. Effect of swainsonine on mouse immunodeficient system and experimental murine tumor. Journal Antibiot. (Tokyo), 38: 936-940, 1985.
26. Olden, K., Breton, P., Grzegorzewski, K., Yasuda, Y., Gause, B.L., Oredipe, O.A., Newton, S.A., and White, S.L. The potential importance of swainsonine in therapy for cancers and immunology. Pharmacol. Ther., 50: 285-290, 1991.
27. Oredipe, O.A., White, S.L., Grzegorzewski, K., Gause, B.L., Cha, J.K., Miles, V.A., and Olden, K. Protective effects of swainsonine on murine survival and bone marrow proliferation during cytotoxic chemotherapy. J. Natl. Cancer Inst., 83: 1149-1156, 1991.
28. White, S.L., Nagai, T., Akiyama, S.K., Reeves, E.J., Grzegorzewski, K., and Olden, K. Swainsonine stimulation of the proliferation and colony forming activity of murine bone marrow. Cancer Commun., 3: 83-91, 1991.
29. White, S.L., Schweitzer, K., Humphries, M.J., and Olden, K. Stimulation of DNA synthesis in murine lymphocytes by the drug swainsonine: immunomodulatory properties. Biochem. Biophys. Res. Commun., 150: 615-625, 1988.
30. Grzegorzewski, K., Newton, S.A., Akiyama, S.K., Sharrow, S., Olden, K., and White, S.L. Induction of macrophage tumoricidal activity, major histocompatibility complex class II antigen (Iak) expression, and interleukin-1 production by swainsonine. Cancer Commun., 1: 373-379, 1989.
31. Breton, P., Asseffa, A., Grzegorzewski, K., Akiyama, S.K., White, S.L., Cha, J.K., and Olden, K. Swainsonine modulation of protein kinase C activity in murine peritoneal macrophages. Cancer Commun., 2: 333-338, 1990.
32. Yagita, M., and Saksela, E. Swainsonine, an inhibitor of glycoprotein processing, enhances cytotoxicity of large granual lymphocytes. Scand. J. Immunol., 31: 275-282, 1990.
33. Novikoff, P.M., Touster, O., Novikoff, A.B., and Tulsiani, D.P. Effects of swainsonine on rat liver and kidney: biochemical and morphological studies. J. Cell Biol., 101: 339-349, 1985.
34. Pritchard, D.H., Huxtable, C.R., Dorling, P.R., and Colegate, S.M. The effect of swainsonine on the growth rate of young rats. In: L.F. James, A.D. Elbein, R.J. Molyneux, and C.D. Warren (eds.), Swainsonine and Related Glycosidase Inhibitors, pp. 360-366, Ames, IA: Iowa State University Press, 1987.
35. Baptista, J.A., Goss, P.E., Nghiem, M., Krepinsky, J.J., Baker, M., and Dennis, J.W. Measurements of swainsonine in the serum of cancer patients: a phase I clinical trial. Clin. Chem., in press, 1994.
36. Stack, R.J., and Sullivan, M.T. Electrophoretic resolution and fluorescence detection of n-linked glycoprotein oligosaccharides after reductive amination with 8-aminonaphthalene-1, 3,6-trisulphonic acid. Glycobiology, 2: 85-92, 1992.
37. McClean, S.W., Ruddel, M.E., Gross, E.G., DeGiovanna, J.L., and Peck, G.L. Liquid-chromatographic assay for retinol (vitamin A) and retinol analogs in therapeutic trials. Clin. Chem., 28: 693-696, 1982.
38. Drug Evaluations Annual 1992, p. 17. Chicago: American Medical Association, 1992.
39. Cummings, R.D., and Kornfeld, S. Characterization of the structural determinants required for the high affinity interaction of asparagine-linked oligosaccharides with immobilized Phaseolus vulgaris leukoagglutinating and erthroagglutinating lectins. J. Biol. Chem., 257: 11230-11234, 1982.
40. De Gasperi, R., Daniel, P.F., and Warren, C.D. A human lysosomal α-mannosidase specific for the core of complex glycans. J. Biol. Chem., 267: 9706-9712, 1992.
41. Dennis, J.W., White, S.L., Freer, A.M., and Dime, D. Carbonoyloxy analogues of the anti-metastatic drug swainsonine: activation in tumor cells by esterases. Biochem. Pharmacol., 46: 1459-1466, 1993.
42. Tulsiani, D.R., Broquist, H.P., James, L.F., and Touster, O. The similar effects of swainsonine and locoweed on tissue glycosidases and oligosaccharides of the pig indicate that the alkaloid is the principal toxin responsible for the induction of locoism. Arch. Biochem. Biophys., 232: 76-85, 1984.
43. Frei, H., Lüthy, J., Brauchli, J., Zweifel, U., Würgler, F.E., and Schlatter, C. Structure/ activity relationships of the genotoxic potencies of sixteen pyrrolidine alkaloids assayed for the induction of somatic mutation and recombination in wing cells of Drosophila melanogaster. Chem.-Biol. Interact., 83: 1-22, 1992.
44. Huan, J., Cheeke, P.R., Lowry, R.R., Nakaue, H.S., Snyder, S.P., and Whanger, P.D. Dietary pyrrolidine (Senecio) alkaloids and tissue distribution of copper and vitamin A in broiler chickens. Toxicol. Lett. (Amst.), 62: 139-153, 1992.
45. Al Daher, S., De Gasperi, R., Daniel, P., Hall, N., Warrern, C.D., and Winchester, B. The substrate-specificity of human lysosomal alpha-D-mannosidase in relation to genetic alpha-mannosidosis. Biochem. J., 277: 743-751, 1991.
46. Tulsiani, D.R., and Touster, O. Substrate specificities of rat kidney lysosomal and cytosolic α-D-mannosidases and effects of swainsonine suggest a role of the cytosolic enzyme in glycoprotein catabolism. J. Biol. Chem., 262: 6506-6514, 1987.
47. Bowlin, T.L., McKown, B.J., Kang, M.S., and Sunkara, P.S. Potentiation of human lymphokine-activated killer cell activity by swainsonine, an inhibitor of glycoprotein processing. Cancer Res., 49: 4109-4113, 1989.
48. Cumming, D.A. Glycosylation of recombinant protein therapeutics: control and functional implications. Glycobiology, 1: 115-130, 1991.
49. Sherblom, A.P., Sathyamoorthy, N., Decker, J.M., and Muchmore, A.V. IL-2, a lectin with specificity for high mannose glycopeptides. J. Immunol., 143: 939-944, 1989.
50. Colombo, M.P., Modesti, A., Parmiani, G., and Forni, G. Local cytokine availability elicits tumor rejection and systemic immunity through granulocyte-T-lymphocyte cross-talk. Cancer Res., 52: 4853-4857, 1992.
51. Baisch, H., Otto, U., and Klöppel, G. Antiproliferative and cytotoxic effects of single and combined treatment with tumor necrosis factor a and/or α-interferon on a human renal cell carcinoma xenotransplanted into nu/nu mice: cell kinetic studies. Cancer Res., 50: 6389-6395, 1990.
52. Hallahan, D.E., Spriggs, D.R., Beckett, M.A., Kufe, W., and Weichselbaum, R.R. Increased tumor necrosis factor a mRNA after cellular exposure to ionizing radiation. Proc. Natl. Acad. Sci. USA, 86: 10104-10107, 1989.